Search

Compugen Ltd

Cerrado

2.28 -2.56

Resumen

Variación precio

24h

Actual

Mínimo

2.26

Máximo

2.34

Métricas clave

By Trading Economics

Ingresos

-65M

-7.7M

Ventas

-65M

2.2M

P/B

Media del Sector

6.158

62.58

BPA

-0.08

Margen de beneficios

-352.436

Empleados

75

EBITDA

-64M

-7.7M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+113.68% upside

Dividendos

By Acuity

Próximas Ganancias

3 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-49M

221M

Apertura anterior

4.84

Cierre anterior

2.28

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 jul 2026, 23:52 UTC

Mexico's Q2 2026 GDP Growth Rate Release on July 30 Amid Cautious Economic Outlook and Market Volatility.

23 jul 2026, 23:52 UTC

Germany's Inflation Rate Release on July 30, 2026 Sparks Market Speculation Amid Cooling Prices and Geopolitical Tensions.

23 jul 2026, 23:52 UTC

Germany's July Inflation Rate Release Sparks Caution Among Investors Amid Rising Oil Prices and Geopolitical Tensions.

23 jul 2026, 23:52 UTC

Japan's June inflation rises to 1.7%, but remains below Bank of Japan’s target, raising concerns over wage growth and global supply chain issues.

23 jul 2026, 23:52 UTC

UK Consumer Confidence Index Improves to -17.0, Exceeding Expectations Amid Positive Market Sentiment and Geopolitical Concerns

23 jul 2026, 23:52 UTC

Australia's S&P Global Manufacturing PMI rises to 51.7 in July, signaling continued growth amid inflationary pressures and increased hiring activity.

23 jul 2026, 23:52 UTC

Australia's S&P Global Services PMI rises to 53.0 in July, signaling growth and boosting economic optimism despite global inflation concerns.

23 jul 2026, 23:52 UTC

New Home Sales Expected at 610,000 Units Amid Rising Mortgage Rates and Declining Buyer Sentiment

23 jul 2026, 23:52 UTC

Cautious Market Sentiment Ahead of U.S. New Home Sales Report Amid Rising Mortgage Rates and Declining Buyer Activity

23 jul 2026, 23:52 UTC

Japan's Retail Sales Expected to Continue Growth Amid Strong Trade Data, but Inflation Concerns Loom Ahead of July 30 Release.

23 jul 2026, 23:52 UTC

Japan's Industrial Production Faces Caution Ahead of July Release Amid Mixed Economic Signals and Rising Inflation.

23 jul 2026, 23:52 UTC

The Nikkei 225 Index is trading lower in after-market hours, continuing its decline since Thursday. No specific news was identified to explain this move.

23 jul 2026, 23:51 UTC

News

Cavco Industries Inc. announced its first-quarter earnings release date, contributing to positive investor sentiment. Shares are higher in after-market trading.

23 jul 2026, 23:51 UTC

Woodward Inc. shares are lower in after-market trading, showing notable volatility with fluctuations between a high of 1.07% and a low of -1.01%.

23 jul 2026, 23:51 UTC

Antero Resources Corp shares are higher in after-market trading, supported by rising crude oil prices amid inflation and interest rate concerns.

23 jul 2026, 23:51 UTC

NewMarket Corp shares are lower in after-market hours, despite earlier gains. The stock is below its 20-day moving average amid inflation concerns.

23 jul 2026, 23:51 UTC

Correlated Moves

Coeur Mining Inc shares are higher in after-market trading, aligning with a positive trend among gold-related equities amid broader market resilience despite bond market instability.

23 jul 2026, 23:51 UTC

Xenon Pharmaceuticals Inc shares are lower in after-market hours, continuing a downward trend with no specific news identified to explain the decline.

23 jul 2026, 23:51 UTC

Under Armour Inc shares are lower in after-market trading, reflecting significant selling pressure despite broader market resilience amid inflation concerns and rising crude oil prices.

23 jul 2026, 23:51 UTC

Southern Co. shares declined after-market, following a volatile session amid broader market resilience and concerns over inflation and rising crude oil prices.

23 jul 2026, 23:51 UTC

News

Scholastic Corp shares fell in after-market trading following fourth-quarter results, where revenue of $476.1 million missed expectations and net income dropped to $9.4 million.

23 jul 2026, 23:51 UTC

Trustmark Corp shares are lower in after-market hours, remaining below their 20-day moving average amid broader market instability reflected in rising credit default swaps.

23 jul 2026, 23:51 UTC

News
Social Media

Leidos Holdings shares are lower in after-market trading amid concerns over long-term revenue growth, despite a backlog of $48.37 billion.

23 jul 2026, 23:51 UTC

RPM International Inc shares are lower in after-market hours, reflecting notable weakness since Thursday's close and positioning below the 20-day moving average.

23 jul 2026, 23:51 UTC

Array Technologies Inc. shares declined after-market, continuing a downward trend since Thursday's close, despite an earlier session rebound from a cumulative low.

23 jul 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

23 jul 2026, 23:51 UTC

Tyson Foods Inc shares are lower in after-market trading, remaining near the lower end of their one-month range amid broader market instability.

23 jul 2026, 23:51 UTC

Spero Therapeutics Inc. shares are lower in after-market hours, continuing a downward trend after five consecutive sessions of declines.

23 jul 2026, 23:51 UTC

Fidelity National Information Services shares are higher in after-market trading, despite earlier session declines and a lack of specific news to explain the movement.

23 jul 2026, 23:51 UTC

American Water Works shares are higher in after-market trading, continuing positive momentum after three consecutive gains and positioning above the 20-day moving average.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

113.68% repunte

Estimación a 12 Meses

Media 5 USD  113.68%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat